MedPlus Health Services subsidiary, Optival Health Solutions Private Limited, has been issued a suspension order for a Drug License concerning one store in Telangana. The suspension is effective for one day, as ordered by the Assistant Director, Drugs Control Administration, Rangareddy. The company estimates the financial impact to be a potential revenue loss of approximately Rs 0.42 lacs, which management deems quantifiable at this stage.
Subsidiary Receives Regulatory Action
A key subsidiary of MedPlus Health Services Limited, Optival Health Solutions Private Limited, has informed the exchanges regarding a suspension order received for one of its operating drug stores located in Kuntloor, Telangana. The regulatory action was formalized through an order received on February 27, 2026, from the Assistant Director, Drugs Control Administration in Rangareddy.
Details of the Suspension Order
The nature of the action taken is the Suspension of Drug License for the specific store, effective for a period of one day. This action appears to stem from alleged violations under Rule 65 of the Drugs and Cosmetics Act, 1940, and the associated Rules of 1945. The company has confirmed that the detailed order, including specific contraventions, has been reviewed internally.
Estimated Financial Impact
MedPlus has quantified the potential financial implication arising directly from this single-day operational halt. The estimated Potential Revenue Loss associated with the suspension is calculated to be Rs 0.42 lacs. The management confirms that this figure is quantifiable at the present time and represents the extent of the impact on the entity’s current financial operations.
Source: BSE
